NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,000 | -40.0% | 144 | +1.4% | 0.00% | 0.0% |
| Q2 2019 | $5,000 | -50.0% | 142 | -51.9% | 0.00% | -50.0% |
| Q1 2019 | $10,000 | -37.5% | 295 | -38.3% | 0.00% | -33.3% |
| Q4 2018 | $16,000 | -44.8% | 478 | +1.5% | 0.00% | -40.0% |
| Q3 2018 | $29,000 | +38.1% | 471 | +8.3% | 0.01% | +66.7% |
| Q2 2018 | $21,000 | -97.1% | 435 | +457.7% | 0.00% | -57.1% |
| Q1 2018 | $735,000 | – | 78 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |